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Abstract Escherichia coli is one of the most frequently
isolated gram-negative pathogens in cases of foodborne
diseases and hospital infections. What is more, diarrheal
diseases, including these associated with pathogenic E. coli
strains, are leading causes of morbidity and mortality
worldwide, especially among children. Improvements of the
management of diarrheal diseases caused by these bacteria
are in the spotlight of the World Health Organization.
Therefore, there is still a need to develop new methods or
improve ones that are commonly used to characterize and
distinguish E. coli strains more precisely. In this work, TRS-
based PCRs were effectively used for discrimination of 123
E. coli strains isolated from children with diarrhea in the
Lodz region (Poland). The composite TRS-PCR approach,
based on similarity comparisons of GTG-PCR and CGG-
PCR fingerprints, enabled us to distinguish strains with very
good efficacy. This was confirmed by the high diversity
index (0.991) and high reproducibility of the band patterns
obtained (95.0 %). These results showed the great variation
in strains that may cause infections in children under
38 months. However, the stains were grouped in three sep-
arate clusters, which were different in terms of their phylo-
genetic affiliation and virulence factor repertoire. The
obtained results support and are consistent with the need of
public health surveillance for searching new and fast assays
as far as children’s health is concerned. TRS-PCRprofiling is
an effective tool for genotyping of E. coli strains isolated
from children with diarrhea.
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Introduction
Diarrheal diseases are common not only in developing
countries but also in industrialized ones, resulting in mor-
bidity and mortality globally, especially among children
[1, 2]. According to the World Health Organization
(WHO), diarrhea and pneumonia kill 2 million children
under 5 years of age every year, of which diarrhea is the
cause of up to 11 % of the deaths [3]. In 2013, 6.3 million
children died before their fifth birthday and 9.2 % of the
deaths were caused by diarrhea (0.578 million cases) [4].
The etiology of the diarrhea differs in terms of region or
population [2], and often its cause remains unidentified [1].
In the case of human enteric infections, Escherichia coli is
an important and widespread pathogen [1, 5–7].
Escherichia coli is a highly diverse bacterial species,
including intestinal and extraintestinal pathogens. Both
groups are further subdivided into pathotypes. A given
pathotype can be stated based on many features, such as the
presence of specific virulence factors, inducement of
specific clinical symptoms, O-serotype and phylogenetic
grouping [1, 6–8]. Diarrheagenic E. coli (DEC) strains are
generally subdivided into seven or eight major groups
[1, 5, 7]. Among them, enteropathogenic (EPEC), entero-
toxigenic (ETEC) and enteroaggregative (EAEC) E. coli
are major causes of children’s diarrhea [1, 5]. Such infec-
tions often have fatal consequences in developing countries
but are mild and self-limiting in industrialized countries
& Marta Majchrzak
mmajchrzak@cbm.pan.pl
1 Institute of Medical Biology, Polish Academy of Sciences,
106 Lodowa, Str., 93-232 Lodz, Poland
2 Laboratory of Personalized Medicine, Lodz Regional Science
and Technology Park Ltd., 114/116 Dubois Str.,
93-465 Lodz, Poland
123
Mol Biol Rep (2016) 43:871–880
DOI 10.1007/s11033-016-4031-x
[1]. Atypical enteropathogenic E. coli (aEPEC) strains
seem to have a predisposition to cause persistent diarrhea
[1] and are more frequently isolated in the developed world
than EPEC [5, 7]. Infections due to Shiga Toxin producing
E. coli (STEC) (including enterohemorrhagic E. coli
strains, EHEC) are relatively rare but a wide spectrum of
illnesses and high mortality rates make these bacteria
emerging pathogens [1, 5]. Some researchers emphasize
that the role of DEC strains as far as sporadic pediatric
diarrhea is concerned is still under-recognized in developed
countries [2]. Moreover, it is known that sometimes a
detected enteric pathogen in a child with diarrhea might not
be the cause of the illness [9]. Two of five of WHO’s main
goals presented in The Integrated Global Action Plan for
the Prevention and Control of Pneumonia and Diarrhoea
(GAPPD) are concentrated on reducing mortality from
diarrhea and reducing the incidence of severe diarrhea in
children under 5 years of age by 2025 [3]. It may be easier
to achieve these goals by conducting studies based on
better characterization of DECs, which further may be
useful in implementation of improvements in public health
monitoring under non-epidemic conditions [2].
Nowadays, detection of DECs and their distinction from
commensal E. coli is based on combination of biochemical
tests, serotyping, virulence profiling and various molecular
methods [2, 5]. Huge progress has been made in detection
of enteropathogens, but molecular biology techniques,
even PCR-based assays are generally limited to reference
laboratories and specifically for outbreak investigations [2].
As there is still a need for simple, fast and inexpensive
methods for discrimination of DEC strains when there is no
ongoing outbreak [2], we present the usefulness of the
TRS-PCR-based technique in distinguishing E. coli strains




All strains were isolated from children with diarrhea in the
Lodz region (Poland) and were obtained from the Medical
Laboratory SYNEVO in Lodz, Poland. Isolates were col-
lected from January 2009 to May 2010. In total, 123 of
E. coli strains originated from stool samples. Pure cultures
were characterized biochemically and resistance to antibi-
otics was specified (SYNEVO). The strains used in this
study were also examined genetically and were serotyped
according to manufacturer’s protocols for E. coli (O pool
and O single antisera, Statens Serum Institut SSI Diag-
nostica, Denmark). Detailed characteristics of the collec-
tion of strains is presented in Table 1.
Bacterial growth and genomic DNA isolation
All of the E. coli strains were grown in a liquid LB broth at
37 C with agitation (120 RPM) for 24 h. Genomic DNA
isolation and purification was performed with the use of a
GenElute Bacterial Genomic DNA Kit (Sigma-Aldrich, St.
Louis, MO). The quantity and purity of each genomic DNA
sample was determined spectrophotometrically at 260 nm
(BioPhotometer, Eppendorf, Germany). The DNA samples
were diluted to 20 ng/ll and then used.
Phylogenetic structure
Assignment of a phylogenetic group was carried out
according to Clermont’s E. coli phylo-typing improved
method [8]. Sequences of primers, their concentrations and
phylo-group detection schemes were conducted strictly as
described in the new quadruplex phylo-group assignment
method [8].
Virulence factors
The presence of uropathogenic virulence factors was
determined using sequences of primers previously pub-
lished [10]. Detection of pathovar target genes (intestinal
virulence factors) was performed according to the Mu¨ller
et al. protocol [5].
Two separate PCRs were performed in order to detect
the presence of an additional five virulence genes. The first
multiplex was composed for determination of iroN, fyuA
and iutA presence. Sequences of primers for iroN detection
as published by Bonacorsi et al. [11], and sequences of
primers for detection of fyuA and iutA as published by
Johnson and Stell [12], were employed. The second one
was composed for determination of sat, as described by
Restieri et al. [13], and for tsh presence, as described by
Moulin-Schouleur et al. [14].
All of the amplifications were performed according to
manufacturers’ guidelines for The Platinum Multiplex
PCR Master Mix (Thermo Fisher Scientific, Foster City,
CA) in a T-3000 thermocycler (Biometra, Goettingen,
Germany). Amplification products were separated on
1.6 % agarose gels in 19 TAE buffer at room temperature
until the dye (bromophenol blue) migrated 6 cm from the
beginning of the gel (2.4 V/cm), ethidium bromide stained,
photographed and analyzed.
TRS-PCR and fingerprint analysis
The conditions for amplification of the TRS profiles,
including primer sequences, electrophoresis, reproducibil-
ity analysis, determination of diversity indices and bioin-
formatic analyses were performed as described elsewhere
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Table 1 E. coli isolates used in this study









I K 037 – M 13 4 O25 A (-)
K 123 – M 1 3 O25 A (-)
K 135 E. coli O125,
fungi
F 11 4 O125 A fimG/fimH
K 098 – M 13 2 O128 A fimG/fimH
K 103 E. coli O128,
fungi
F 21 2 O142 B1 fimG/fimH
K 118 Fungi M 30 4 O128 B1 fimG/fimH
K 057 – F 9 4 O25 B1 fimG/fimH
K 053 Fungi M 31 4 O86 B1 fimG/fimH
K 162 – M 34 4 O55 A fimG/fimH
K 048 – M 20 3 O128 A fimG/fimH
K 100 Fungi M 9 4 O128 A fimG/fimH
K 007 MSSA M 7 4 O126 A fimG/fimH
K 121 Fungi M 23 3 O111 B1 fimG/fimH, escV
K 133 MRSA, fungi F 17 4 O128 B1 fimG/fimH, escV
K 032 Fungi M 1 4 O128 B1 fimG/fimH, escV
K 160 – F 12 4 O128 B1 fimG/fimH, escV
K 128 – F 36 4 O55 E fimG/fimH, escV
K 106 Fungi M 19 7 nt E fimG/fimH, escV
K 046 Fungi M 26 4 O157 E fimG/fimH, escV, stx2
K 138 – M 2 4 O127 A fimG/fimH, fyuA
K 096 – F 3 1 O-rough A fimG/fimH, fyuA
K 071 – M 31 1 nt A fimG/fimH, fyuA
K 044 Fungi M 20 4 O125 A fimG/fimH, fyuA
K 064 Fungi F 3 3 O126 A fimG/fimH, fyuA
K 028 Fungi M 10 4 nt F papC, fimG/fimH, fyuA
K 122 Fungi M 17 3 O26 B1 fimG/fimH, escV, fyuA
K 132 Fungi F 15 2 O128 A fimG/fimH, astA, fyuA
K 027 S. Enteritidis,
fungi
M 15 4 O126 A fimG/fimH, iutA
K 010 MSSA F 3 4 O126 A fimG/fimH, iutA
K 029 Fungi M 12 4 nt E fimG/fimH, escV, iutA
K 015 – M 8 3 nt E fimG/fimH, astA, iutA
K 116 Fungi M 12 1 O26 B1 fimG/fimH, escV, fyuA, iutA
K 126 – F 11 4 O26 B1 fimG/fimH, escV, fyuA, iutA
K 008 – M 8 4 O26 B1 fimG/fimH, escV, fyuA, iutA
K 012 – M 11 4 O26 B1 fimG/fimH, escV, stx1, fyuA, iutA
K 142 MRSA F 4 4 O119 F fimG/fimH, fyuA, iutA, iroN
K 011 Fungi F 31 4 O125 A fimG/fimH, fyuA, iutA, iroN
K 074 S. Enteritidis F 11 4 O25 F papC, fimG/fimH, fyuA, iutA, iroN
K 078 – M 14 4 O25 F papC, fimG/fimH, fyuA, iutA, iroN
K 073 Fungi F 32 4 nt F fimG/fimH, fyuA, iutA, iroN, tsh
K 134 Fungi F 30 4 O126 B1 papC, fimG/fimH, fyuA, iutA, iroN,
tsh
K 033 – F 24 4 O124 A fimG/fimH, sat
K 014 – M 4 2 O25 B2 papC, sfaD/sfaE, cnf1, usp, hly1,
fimG/fimH, fyuA, sat
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K 051 Fungi M 38 4 O86 A papC, hly1, fimG/fimH, pic, astA,
iutA, sat
K 076 Fungi M 17 4 O86 D fimG/fimH, fyuA, iutA, sat
K 127 Fungi M 25 4 O86 A papC, hly1, fimG/fimH, pic, aggR,
astA, fyuA, iutA, sat
II K 002 Fungi M 30 4 O25 B2 papC, fimG/fimH
K 120 Fungi M 24 4 O114 B2 fimG/fimH, escV
K 018 Fungi F 5 4 O25 B2 papC, fimG/fimH, iutA
K 021 Fungi M 5 4 O25 B2 papC, fimG/fimH, fyuA, iutA
K 060 Fungi F 27 4 O25 B2 papC, fimG/fimH, fyuA, iutA
K 025 – F 33 4 O25 B2 papC, cnf1, hly1, fimG/fimH, fyuA,
iutA
K 034 – M 8 4 O25 B2 fimG/fimH, fyuA, iroN
K 035 – M 8 4 O25 B2 fimG/fimH, fyuA, iroN
K 005 MSSA M 4 4 O25 B2 papC, fimG/fimHfyuA, iroN
K 108 – M 24 4 O25 B2 fimG/fimH, astA, fyuA, iroN
K 043 Fungi M 9 4 O25 B2 papC, fyuA, iutA, iroN
K 036 Fungi M 24 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 141 S. Enteritidis M 31 4 O25 B1 papC, fimG/fimH, fyuA, iutA, iroN
K 023 Fungi M 14 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 137 MRSA F 14 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 115 Fungi M 29 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 001 Fungi F 11 2 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 017 – F 9 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 099 – M 2 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 117 MRSA F 5 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 124 S. Enteritidis,
MSSA, fungi
F 25 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 059 Fungi M 7 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 049 – M 31 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 052 – M 17 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 094 – M 19 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN
K 009 – F 1 4 O25 B2 fimG/fimH, fyuA, iutA, tsh
K 082 Fungi F 25 4 O25 B2 fimG/fimH, fyuA, iutA, iroN, tsh
K 031 – M 10 4 O25 B2 fimG/fimH, fyuA, iutA, iroN, tsh
K 013 – M 4 4 O25 B2 fimG/fimH, fyuA, iutA, iroN, tsh
K 026 – F 7 7 O25 B2 fimG/fimH, fyuA, iutA, iroN, tsh
K 075 – F 25 4 O25 B2 fimG/fimH, fyuA, iutA, iroN, tsh
K 016 Fungi M 8 7 nt B2 fimG/fimH, sat
K 030 Fungi M 11 7 nt B2 fimG/fimH, sat
K 038 Fungi F 28 4 nt B2 fimG/fimH, fyuA, iutA, sat
K 084 Fungi M 31 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 114 – M 20 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 067 – M 31 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 112 – M 20 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 055 Fungi M 25 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 039 MRSA F 22 4 nt B2 fimG/fimH, fyuA, iutA, sat
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K 129 Fungi F 12 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 110 – F 10 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 080 – F 17 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 085 MRSA, fungi F 22 4 O25 B2 fimG/fimH, fyuA, iutA, sat
K 061 – F 23 4 nt B2 fimG/fimH, fyuA, iutA, sat
K 042 MSSA, fungi M 18 6 O25 B2 fimG/fimH, fyuA, iutA, sat
K 077 Fungi M 20 6 O25 B2 fimG/fimH, fyuA, iutA, sat
K 090 – F 36 4 O25 F fimG/fimH, fyuA, iutA, sat
K 004 MSSA, fungi M 27 4 O25 B2 fimG/fimH, fyuA, iroN, sat
K 041 MSSA, fungi F 21 4 O25 B2 papC, fimG/fimH, fyuA, iutA, iroN,
sat
III K 102 – F 31 4 nt D fimG/fimH
K 093 Fungi F 33 4 O44 D fimG/fimH, fyuA
K 140 – M 6 4 O142 B1 fimG/fimH, astA, iroN
K 062 – M 7 2 O25 B2 papC, sfaD/sfaE, cnf1, usp, hly1,
fimG/fimH, fyuA, iutA, iroN
K 066 – F 13 2 O44 D fimG/fimH, sat
K 020 Fungi M 23 4 nt D fimG/fimH, sat
K 022 Fungi F 14 4 nt D fimG/fimH, sat
K 003 Fungi M 18 4 O86 D papC, fimG/fimH, astA, sat
K 040 Fungi M 19 4 nt D fimG/fimH, iutA, sat
K 089 Fungi F 8 2 nt D fimG/fimH, iutA, sat
K 104 – F 31 4 O44 D fimG/fimH, iutA, sat
K 111 Fungi F 22 2 nt D fimG/fimH, iutA, sat
K 097 Fungi F 17 2 nt D fimG/fimH, iutA, sat
K 113 – M 33 3 nt D fimG/fimH, iutA, sat
K 065 – F 13 4 nt D fimG/fimH, iutA, sat
K 083 Fungi F 16 2 nt D fimG/fimH, iutA, sat
K 079 fungi F 23 4 nt D fimG/fimH, iutA, sat
K 095 – F 31 4 nt D fimG/fimH, iutA, sat
K 063 Fungi F 24 3 nt D fimG/fimH, iutA, sat
K 081 – M 24 4 nt D fimG/fimH, iutA, sat
K 087 Fungi F 21 3 nt D fimG/fimH, iutA, sat
K 086 MRSA, S.
Enteritidis,
fungi
F 36 4 O44 D fimG/fimH, iutA, sat
K 024 – F 20 4 nt D fimG/fimH, fyuA, iutA, sat
K 072 Y. enterocolitica.,
fungi
F 7 4 O44 D papC, fimG/fimH, fyuA, iutA, sat
K 091 – F 18 4 nt D papC, fimG/fimH, fyuA, iutA, sat
K 019 Fungi M 20 5 nt D fimG/fimH, fyuA, iutA, iroN, sat
K 006 – M 15 4 nt D fimG/fimH, fyuA, iutA, iroN, sat
a M/F—male/female
b Place of isolation—different numbers refer to different regions; 1 Aleksandrow Lodzki, 2 Dlutow, 3 Leczyca, 4 Lodz, 5 Piotrkow Trybulanski,
6 Radomsko, 7 Tuszyn
c nt non-typable
(-) none of the studied virulence factors identified
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[10, 15–18]. One exception was DNA concentration—for
each amplification, 20 ng of genomic DNA was used. For
each strain, two fingerprint types based on the presence of
CGG or GTG motif were generated. The PCRs were per-
formed in a T3000 Biometra thermal cycler. Amplification
products were separated on 1.6 % agarose gels in 19 TAE
buffer, ethidium bromide stained and photographed. Sub-
sequently, gels were optimized according to recommen-
dations provided by BioNumerics software (Applied
Maths, Belgium) and normalized with regard to a 100 bp
Plus DNA size marker (Fermentas, Thermo Scientific
Waltham, MA, USA). The composite (mean) fingerprint
similarity analysis based on CGG-PCR and GTG-PCR
fingerprints using Pearson correlation (optimization 1 %,
position tolerance 1 %) and grouping according to the
UPGMA algorithm was performed.
Results
Phylogenetic structure and virulence profiling
of the E. coli collection
The distribution of phylogenetic groups among E. coli
strains was as follows: 20 strains were represented by
phylogroup A, 16 by B1, 50 by B2, 26 by D, 5 by E and 6
strains were represented phylogroup F. Phylogroup C was
not detected in the collection. All this information is
gathered in Table 1.
A virulence profile was defined for each of the 123 E. coli
strains (Table 1). Among this group of strains, 39 unique
virulence profiles were identified, which makes this collec-
tion very heterogeneous. Three profiles—fimG/fimH, fyuA,
iutA, sat (17 strains), papC, fimG/fimH, fyuA, iutA, iroN (16
strains) and fimG/fimH, iutA, sat (14 strains)—were pre-
dominant (Table 1). What is interesting is that 11 strains had
a single-gene virulence profile—fimG/fimH—and 2 strains
had none of the analyzed virulence genes (Table 1).
TRS-PCR and fingerprint analysis
The (CGG)4- and (GTG)4-based PCR tests were conducted
on a collection of 123 E. coli strains. Both tests generated
fingerprints for each strain. Reproducibility analyses for
these tests were calculated and found to be at a very similar
level. When used separately, it was 96.2 % for CGG-PCR
and 95.0 % for GTG-PCR. For the composite analysis, it
exhibited 95.0 %. Two separate analyses of fingerprint
similarity were made for both TRS-PCR tests and diversity
indices (DI) according to the Hunter and Gaston algorithm
[19] that had been calculated for them. The DI value for
CGG-PCR and GTG-PCR were 0.987 and 0.951,
respectively.
Based on that, a composite analysis of CGG-PCR and
GTG-PCR fingerprint similarity was conducted. For this
analysis, the diversity index (DI) had been calculated. Its
value was high—0.991—which confirms the utility of the
applied test for diversification of those E. coli strains. The
calculated parameters allowed for distinguishing 87 clus-
ters, which means 87 unique fingerprints for 123 isolates.
Taking this composite analysis into consideration, one
may notice the strains grouped into three separate clusters
(Fig. 1). These clusters were different with regard to phy-
logenetic structure and virulence profiles. Inter-cluster
similarities were 43.36, 51.58 and 47.47 %, respectively.
Among the first cluster, 44 % of the strains were repre-
sented by phylogroup A and 30 % by B1. Also, there were
strains belonging to phylogroup E (11 %), F (11 %), B2
(2 %) and D (2 %) (Table 1; Fig. 1). What is more, there
were 22 different virulence profiles for 46 strains in this
cluster (Fig. 2).
The phylogenetic structure in the second cluster strains
was as follows: 96 % of the strains belonged to phylogroup
B2, one strain to B1 and one to phylogroup F (Table 1;
Fig. 1). In the second cluster, there were 50 strains,
revealing 16 different virulence profiles (Fig. 2.).
Analysis of the third cluster revealed that most of the
strains belonged to phylogenetic group D (92 %). There
were strains representing phylogroup B1 and B2, 4 % each
(Table 1; Fig. 1). Twenty-seven strains from this cluster
had 9 distinguishing virulence profiles (Fig. 2.).
Discussion
Infections due to enteropathogens still pose a serious threat
in many regions of the world. Children from high- and low-
income countries are at the center of attention of many
authorities from the viewpoint of diarrheal diseases
[2, 3, 9]. It is known that in the case of children, enteric
infections are not always caused by one pathogen or that
the detected pathogen is the cause of the illness [9]. In our
study concomitant infections were also observed (Table 1).
To accomplish guidelines resulting from WHO’s GAPPD
project [3] and taking into consideration many statistics
associated with children’s morbidity and mortality [4],
there are many issues that may be done in the field of
E. coli infections in children.
Some researchers underline that studies on DECs are
very needed, not only to widen the general knowledge
about these strains but also to follow changes in new
emerging pathotypes, which will be useful in making epi-
demic predictions [1, 2, 9]. From our point of view,
improving and implementing more accurate and easy
methods useful in epidemiology of pathogenic E. coli
strains are among such activities. We showed earlier that
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Fig. 1 The composite CGG-
TRS and GTG-TRS fingerprints
similarity comparison of 123
E. coli strains isolated from
children with diarrhea and
phylogenetic composition
within clusters. Black dots
indicate an example of three
strains with identical virulence
factors, the same phylogroup
and O-antigen. Grey zones—





1.00 %, position tolerance
1.00 %) and fingerprints were
grouped by use of the UPGMA
algorithm
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Fig. 2 Virulence profiles within clusters (A - cluster I, B - cluster II, C - cluster III) of E. coli strains
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TRS-PCR was an effective tool for differentiation of UPEC
strains [10]. In this paper, composite analysis based on
CGG-PCR and GTG-PCR fingerprints was conducted on a
collection of E. coli strains isolated from children with
diarrhea (Fig. 1). From the group of 10 CG-rich TRS pri-
mers, we chose those with CGG and GTG motifs. CGG-
PCR was effectively used for discrimination of the UPEC
strains [10], so we assumed that it could also be useful in
the case of intestinal E. coli. The GTG-PCR was chosen as
it was successfully employed in our laboratory for inter-
serovar discrimination of Salmonella strains [15]. What is
more, (GTG)5-PCR tests were used for genotyping Kleb-
siella strains [20] and identification of Streptococcus
mutans, Staphylococcus spp. and Enterococcus spp
[21–23]. In this work, we decided on composite analysis of
these two tests because, in general, composite analysis of
two methods yields better results. This fact was confirmed
by DI values—the highest value was obtained for the
composite analysis demonstrating 88 unique TRS profiles
(Fig. 1).
Taking the structure of the dendrogram into considera-
tion, it can be noticed that fingerprints obtained for this
collection of E. coli might be used for strain diversification.
This was verified by the DI value of 0.991 and high
reproducibility (95.0 %). Noteworthy, CGG-PCR and
GTG-PCR profiles for these strains may enable phyloge-
netic investigations. Distribution of the phylogenetic
groups represented by tested isolates within the dendro-
gram differed between three distinct clusters. Most of the
strains in the first cluster represented phylogroup A and B1
(74 %) (Fig. 1). Strains belonging to phylogroup B2 were
predominant in the second cluster (96 %), and those
belonging to phylogroup D prevailed in the third cluster
(92 %) (Fig. 1). Strains of phylogroups B2 and D are more
typical of those that cause extraintestinal infections, while
intestinal pathogens more often belong to phylogroup D
than B2, B1 or A [24]. Commensal strains of E. coli gen-
erally represent phylogroups A and B1—potentially non-
harmful intestinal isolates [24]. As our study shows, viru-
lence factors typical for IPEC were rarely detected in our
collection, but other virulence factors were found
(Table 1). When analyzing the dendrogram presented in
Fig. 1, one may notice that strains encoding virulence
factors typical for IPEC were mostly grouped in the first
cluster (15 of the 16 strains). However, this cluster also
includes strains that do not have any of these VFs. Because
strains in this cluster represented phylogenetic groups
typical for intestinal isolates, one may suppose that this is a
mixed group with potential pathogens and commensal
strains. Commensal E. coli strains seldom are causes of
diseases, but the exceptions are debilitated or immuno-
compromised hosts or sensitive individuals, for example,
after previous antibiotic treatment or those with some
bowel diseases [6, 7, 9]. Many of the tested isolates were
derived from children with some additional microbiologi-
cal infections (Table 1), but we had no information about
other diseases or viral infections. Thus, since the morbidity
also depends on the condition of the host, and bearing in
mind all that is mentioned above, it is obvious that children
are a very specific target for intestinal infections due to
E. coli and that even a potentially non-harmful strain may,
in convenient conditions, become a nagging pathogen and
cause dangerous diarrhea.
In this paper, we propose a complex approach to
genotyping of E. coli isolated from children with diarrhea,
in which the presence of many virulence factors and TRS-
PCR profiles were determined. It should be underlined that
virulence factors are not restricted to one pathovar and can
occur in other pathotypes, which influence the virulence
potential of the strain [5]. This indicates that epidemio-
logical assays should not be based on virulence profiling
only. Our complex approach allowed for better diversifi-
cation of strains encoded with the same virulence profiles
and, in some cases, which belonged to the same phyloge-
netic group yet had different TRS-PCR fingerprints
(marked in Fig. 1). However, the strains with identical
TRS-PCR profiles and different VF set such as: K001,
K002, K009, K013 and K017 or K035 and K036, should be
additionally sub-typed. Analyzes employing other TRS
primers demonstrated, that some of these strains could be
separated by CAC-PCR (data not shown). It cannot be
excluded that TRS-PCR profiling might not be sufficient
for a full differentiation, therefore should be combined with
virulence gene detection, serogrouping or phylogenetic
affiliation [25].
For molecular diagnostics and DNA-based strain typing
such methods as PFGE, MLVA orMLST are routinely used.
Without comparative analyzes, it is hard to asses if TRS-PCR
profiling has superior power to the these methods. Accepting
that TRS-PCR has comparable resolution, it is still inex-
pensive, rapid and easy applicable among routinely used
approaches. The obtained results support and are consistent
with the need of public health surveillance for searching new
and fast assays as far as children’s health is concerned. To
sum up, TRS-PCR profiling is an effective tool for geno-
typing E. coli strains isolated from children with diarrhea.
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